The national Medicines Safety Improvement Programme aims to help patients get the maximum benefit from their medicines and reduce waste with an overarching aim to reduce medication related harm in health and social care.
The programme (known as MedSIP) is led by NHS England’s patient safety team, and delivered locally by the West of England Patient Safety Collaborative.
Our local delivery will focus on improving the care of people living with non-cancer chronic pain by reducing the prescribing of high risk opioids.
There is no evidence for the efficacy of high dose opioids (>120mg/day morphine equivalent) on long term pain. The Faculty of Pain Medicine has advised that increasing opioid load above this dose is unlikely to yield further benefits but exposes the patient to increased harm. Despite this, Public Health England’s review (2019) shows that in 2017 to 2018, 540,000 adults in England were prescribed opioid pain medicines for 3 years or more.
The effects of COVID-19 are anticipated to have exacerbated the use of opioids for chronic pain, which is linked to both deprivation and the prevalence of mental health conditions such as anxiety.
Approach and resources
To support a reduction in the prescribing of high risk opioids across the region’s three systems, we are sharing free resources and learning opportunities.
On 3 August 2022 we held a webinar to inform colleagues across the region about this work. A recording of this event is available here:
We are also working closely with Bath, Swindon and Wiltshire Together using the following framework:
- Phase one: set-up
- Phase two: building the ICS picture
- Phase three: mapping the ICS picture
- Phase four: action planning
- Phase five: managing the Network
- Phase six: action
- Phase seven: quality improvement to quality control
Find out more and keep in touch
For more information, please contact Senior Project Manager, Christopher Learoyd.
Read more about our regional projects to support medicines optimisation.
You can also sign-up to receive our monthly newsletter.